JP2003500341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003500341A5 JP2003500341A5 JP2000619018A JP2000619018A JP2003500341A5 JP 2003500341 A5 JP2003500341 A5 JP 2003500341A5 JP 2000619018 A JP2000619018 A JP 2000619018A JP 2000619018 A JP2000619018 A JP 2000619018A JP 2003500341 A5 JP2003500341 A5 JP 2003500341A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tyr
- peptide
- asp
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13440699P | 1999-05-17 | 1999-05-17 | |
| US60/134,406 | 1999-05-17 | ||
| PCT/IB2000/000763 WO2000070665A2 (en) | 1999-05-17 | 2000-05-17 | Long lasting anti-angiogenic peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008008554A Division JP2008110986A (ja) | 1999-05-17 | 2008-01-17 | 長期持続性抗新脈管形成ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003500341A JP2003500341A (ja) | 2003-01-07 |
| JP2003500341A5 true JP2003500341A5 (enExample) | 2006-01-05 |
| JP4209086B2 JP4209086B2 (ja) | 2009-01-14 |
Family
ID=22463240
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000619018A Expired - Fee Related JP4209086B2 (ja) | 1999-05-17 | 2000-05-17 | 長期持続性抗新脈管形成ペプチド |
| JP2008008554A Withdrawn JP2008110986A (ja) | 1999-05-17 | 2008-01-17 | 長期持続性抗新脈管形成ペプチド |
| JP2009023118A Withdrawn JP2009143941A (ja) | 1999-05-17 | 2009-02-03 | 長期持続性抗新脈管形成ペプチド |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008008554A Withdrawn JP2008110986A (ja) | 1999-05-17 | 2008-01-17 | 長期持続性抗新脈管形成ペプチド |
| JP2009023118A Withdrawn JP2009143941A (ja) | 1999-05-17 | 2009-02-03 | 長期持続性抗新脈管形成ペプチド |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1171582A2 (enExample) |
| JP (3) | JP4209086B2 (enExample) |
| CN (2) | CN1698881A (enExample) |
| AU (1) | AU764103B2 (enExample) |
| CA (1) | CA2373252C (enExample) |
| SM (1) | SM200000031A (enExample) |
| TW (1) | TWI300414B (enExample) |
| WO (1) | WO2000070665A2 (enExample) |
| ZA (2) | ZA200106676B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030054988A1 (en) * | 2000-11-02 | 2003-03-20 | Weidong-Richard Ji | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
| WO2002066511A2 (en) | 2001-02-16 | 2002-08-29 | Conjuchem Inc. | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| DE60216151T2 (de) | 2001-05-31 | 2007-09-27 | ConjuChem Biotechnologies Inc., Montreal | Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion |
| AU2003246500A1 (en) * | 2002-07-31 | 2004-02-16 | Conjuchem Biotechnologies Inc. | Long lasting natriuretic peptide derivatives |
| JP5385497B2 (ja) | 2002-09-24 | 2014-01-08 | フロンティア バイオテクノロジーズ カンパニー リミテッド | Hiv感染のペプチド誘導体融合阻害剤 |
| PT2100904E (pt) | 2004-04-23 | 2010-09-24 | Conjuchem Biotechnologies Inc | Fase sólida para utilização num método para a purificação de conjugados de albumina |
| CN103897031A (zh) * | 2012-12-25 | 2014-07-02 | 深圳先进技术研究院 | 化学修饰的胸腺五肽及其合成方法 |
| CN104892725A (zh) * | 2015-05-19 | 2015-09-09 | 广州诺威生物技术有限公司 | 一种萘乙酰胺新化合物 |
| CN109503700A (zh) * | 2017-09-14 | 2019-03-22 | 南京安吉生物科技有限公司 | 马来酰亚胺基团修饰的血管生成抑制剂hm-1及其应用 |
| CN110372781B (zh) * | 2019-07-29 | 2021-11-16 | 深圳佳肽生物科技有限公司 | 恩夫韦肽的制备方法和应用 |
| CN117186187B (zh) * | 2023-07-12 | 2024-05-31 | 中国医学科学院病原生物学研究所 | 一种抗呼吸道合胞病毒膜融合抑制剂及其药物用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0602290B1 (en) * | 1992-12-04 | 1999-08-25 | ConjuChem, Inc. | Antibody-conjugated Hepatitis B surface antigen and use thereof |
| WO1997023500A1 (en) * | 1995-12-13 | 1997-07-03 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
| HU224827B1 (hu) * | 1996-05-03 | 2006-02-28 | Abbott Lab | Új antiangiogén peptidek, azokat kódoló polinukleotidok, és eljárások angiogenezis gátlására |
| CA2305597C (en) * | 1997-11-07 | 2008-07-29 | Conjuchem Inc. | Affinity markers for human serum albumin |
| ES2173641T3 (es) * | 1997-11-07 | 2002-10-16 | Conjuchem Inc | Composicion de derivados opiaceos para la fabricacion de medicamentos. |
| AU748496B2 (en) * | 1998-03-23 | 2002-06-06 | Conjuchem, Inc. | Local delivery of long lasting therapeutic agents |
| GB9815505D0 (en) * | 1998-07-16 | 1998-09-16 | Adprotech Plc | Polypeptide derivatives |
-
2000
- 2000-05-17 EP EP00929748A patent/EP1171582A2/en not_active Withdrawn
- 2000-05-17 CN CNA2005100059909A patent/CN1698881A/zh active Pending
- 2000-05-17 JP JP2000619018A patent/JP4209086B2/ja not_active Expired - Fee Related
- 2000-05-17 AU AU47748/00A patent/AU764103B2/en not_active Ceased
- 2000-05-17 CA CA002373252A patent/CA2373252C/en not_active Expired - Fee Related
- 2000-05-17 WO PCT/IB2000/000763 patent/WO2000070665A2/en not_active Ceased
- 2000-05-17 CN CNA2008100915043A patent/CN101289500A/zh active Pending
- 2000-06-19 TW TW094112549A patent/TWI300414B/zh not_active IP Right Cessation
- 2000-10-09 SM SM200000031A patent/SM200000031A/it unknown
-
2001
- 2001-08-14 ZA ZA200106676A patent/ZA200106676B/en unknown
- 2001-11-05 ZA ZA200109110A patent/ZA200109110B/en unknown
-
2008
- 2008-01-17 JP JP2008008554A patent/JP2008110986A/ja not_active Withdrawn
-
2009
- 2009-02-03 JP JP2009023118A patent/JP2009143941A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2363712A1 (en) | Long lasting insulinotropic peptides | |
| ES2303361T3 (es) | Conjugados de interferon-alfa-polimero con actividad biologica potenciada y procedimientos de preparacion de los mismos. | |
| CA2176229C (en) | Improved interferon polymer conjugates | |
| ES2210808T3 (es) | Composiciones y su uso para prevenir la formacion de adherencias en un tejido biologico. | |
| US5738846A (en) | Interferon polymer conjugates and process for preparing the same | |
| KR100345214B1 (ko) | 생체적합성 고분자가 수식된 펩타이드의 비점막 전달 | |
| JP4175668B2 (ja) | Ob融合タンパク質組成物および方法 | |
| JP4027663B2 (ja) | ポリマー安定化神経ペプチド | |
| JP2003508350A5 (enExample) | ||
| JP2006514607A5 (enExample) | ||
| WO2003094849A3 (en) | Ferritin fusion proteins for use in vaccines and other applications | |
| JP2003500341A5 (enExample) | ||
| CA2064689A1 (en) | Stabilized protein or peptide conjugates | |
| JP2002206000A5 (enExample) | ||
| WO2002043746A3 (en) | Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension | |
| JP2001510028A5 (enExample) | ||
| WO2003037272A3 (en) | Thymosin alpha 1 peptide/polymer conjugates | |
| WO2000070665A3 (en) | Long lasting anti-angiogenic peptides | |
| Smith et al. | Chemical derivatization of therapeutic proteins | |
| JPH01131197A (ja) | Anf活性を有するペプチド類 | |
| WO2001042423A3 (en) | Compositions and methods for detecting stress-inducible proteins | |
| NZ513915A (en) | Chimeric proteins comprising 6 contiguous amino acids that bind to the GIT fused to a second protein, which may be a drug | |
| JP2001269184A5 (enExample) |